Clínica Universitaria de Navarra -ko ikertzaileekin lankidetzan egindako argitalpenak (20)

2019

  1. Improvement of appropriate pharmacological prophylaxis in hospitalised cancer patients with a multiscreen e-alert system: a single-centre experience

    Clinical and Translational Oncology, Vol. 21, Núm. 6, pp. 805-809

2018

  1. Insights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective study

    PLoS ONE, Vol. 13, Núm. 8

2016

  1. Identification of new markers of recurrence in patients with unprovoked deep vein thrombosis by gene expression profiling: the retro study

    European Journal of Haematology, Vol. 97, Núm. 2, pp. 128-136

  2. Short Leukocyte Telomere Length Is Associated with Cardioembolic Stroke Risk in Patients with Atrial Fibrillation

    Stroke, Vol. 47, Núm. 3, pp. 863-865

2015

  1. Factors influencing the use of thromboprophylaxis in cancer outpatients in clinical practice: A prospective study

    Thrombosis Research, Vol. 136, Núm. 6, pp. 1145-1148

2014

  1. Laparoscopic limited liver resection decreases morbidity irrespective of the hepatic segment resected

    HPB, Vol. 16, Núm. 4, pp. 320-326

2013

  1. High incidence of venous thromboembolism despite electronic alerts for thromboprophylaxis in hospitalised cancer patients

    Thrombosis and Haemostasis, Vol. 110, Núm. 1, pp. 184-190

2005

  1. Autoantibodies against the endothelial receptor of protein C are associated with acute myocardial infarction in young women

    Journal of Thrombosis and Haemostasis, Vol. 3, Núm. 7, pp. 1454-1458

2003

  1. Tumor necrosis factor-α inhibition reduces CXCL-8 levels but fails to prevent fibrin generation and does not improve outcome in a rabbit model of endotoxic shock

    Journal of Laboratory and Clinical Medicine, Vol. 141, Núm. 4, pp. 257-264

2002

  1. Differential effects of 2C9*3 and 2C9*2 variants of cytochrome P-450 CYP2C9 on sensitivity to acenocoumarol

    Blood, Vol. 99, Núm. 11, pp. 4237-4239

  2. The endotoxin-induced plasminogen activator inhibitor-1 increase in rabbits is not tumor necrosis factor-α dependent and can occur in the absence of interleukin-1β

    Thrombosis and Haemostasis, Vol. 88, Núm. 4, pp. 639-643

2000

  1. Prevention of renal fibrin deposition in endotoxin-induced DIC through inhibition of PAI-1

    Thrombosis and Haemostasis, Vol. 84, Núm. 1, pp. 65-70

1999

  1. Effect of the administration of recombinant hirudin and/or tissue- plasminogen activator (t-PA) on endotoxin-induced disseminated intravascular coagulation model in rabbits

    British Journal of Haematology, Vol. 105, Núm. 1, pp. 117-121

  2. Effects of low molecular weight heparin, alone or combined with antithrombin III, on mortality, fibrin deposits and hemostatic parameters in endotoxin-induced disseminated intravascular coagulation in rabbits

    American Journal of Hematology, Vol. 60, Núm. 1, pp. 6-11

1998

  1. Endotoxin-induced disseminated intravascular coagulation in rabbits: Effect of recombinant hirudin on hemostatic parameters, fibrin deposits, and mortality

    Journal of Laboratory and Clinical Medicine, Vol. 131, Núm. 1, pp. 77-83

  2. Infusion of anti-PAI-1 monoclonal antibodies to rabbits given endotoxin to induce DIG

    Fibrinolysis and Proteolysis, Vol. 12, Núm. SUPPL. 1, pp. 6

1997

  1. Otros estados de hipercoagulabilidad adquiridos

    Sangre, Vol. 42, Núm. 6, pp. 482-492

1996

  1. Aprotinina en el control de las hemorragias en cirugía

    Medicina Clinica, Vol. 106, Núm. 8, pp. 307-316

  2. Contribution of cytokines to hyperf ibrinolysis during orthotopic liver transplantation and effect of aprotinin

    Fibrinolysis, Vol. 10, Núm. 5-6, pp. 325-329

1993

  1. ASOCIACION DE POLICITEMIA VERA Y MIELOMA MULTIPLE. PRESENTACION DE UN NUEVO CASO Y REVISION DE LA LITERATURA

    Sangre, Vol. 38, Núm. 6, pp. 497-499